Author:
Xu Hongfa,Jin Xiaoqin,Chen Man,Zhang Dingyue,Yang Shaoxiu,Han Han,Ou Lirong,Li Tuhua,Liang Qi-Lian,Cai De
Reference48 articles.
1. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;J C Yao;J Clin Oncol,2008
2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States;A Dasari;JAMA Oncol,2017
3. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites;T Y Sun;Endocr Relat Cancer,2022
4. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer;B Kleist;Int J Clin Exp Pathol,2014
5. Basic and translational research progress of gastrointestinal neuroendocrine neoplasmas];Y Song;Zhonghua Wei Chang Wai Ke Za Zhi,2016